Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Karimah Es Sabar

Director at Capricor Therapeutics, Inc. (CAPR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.8M

Reported trades

Filed Stock Type Shares Price Value Since
Apr 3SEC CAPRCapricor Therapeutics, Inc. Sell Plan 7,529 $32.00 $241K -79.0%
Apr 1SEC CAPRCapricor Therapeutics, Inc. Sell Plan 61,265 $30.17 $1.8M -77.8%
Apr 1SEC CAPRCapricor Therapeutics, Inc. Sell Plan 53,735 $31.03 $1.7M -78.4%
  • Sell

    Director Karimah Es Sabar sold $241K of CAPR at $32.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Karimah Es Sabar sold $1.8M of CAPR at $30.17 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Karimah Es Sabar sold $1.7M of CAPR at $31.03 — pre-scheduled 10b5-1 plan sale.